	Liver findings in newly diagnosed, treatment-naive patients with Crohn's disease: a preliminary study of MRI proton density fat fraction and extracellular volume fraction. BMC Med Imaging Zhu L, Zhang Z, Ma Y, Cui B, Zhang F, Asnake MA, Zhou J, Zhu J. PMID: 42443825 [PubMed - as supplied by publisher]
	Study of ectodomain of type 23 collagen as a novel marker of disease activity in patients with ulcerative colitis disease. Egypt J Immunol Dawod AGA, Sayed KAM, Raafat KMA, Ghait SSA, Ali MEA, Huessin SHG. PMID: 42441762 [PubMed - indexed for MEDLINE]
	A scoping review on emerging biomarkers in inflammatory bowel disease: Towards precision medicine in diagnosis and therapeutic management. PLoS One da Silva MQ, Souza Menezes JD, Esteves Francisco JL, Michele da Silva F, Rocha PCV, de Oliveira Ruiz PB, Dos Santos Costa CC, de Amorin LF, Vaz Nunes CA, de Almeida Neto NSG, Dos Santos LA, Constancio GR, Mendes MC, Bernardes da Rosa AP, Rondina NF, Cristovão SAB, Furlani MR, de Sales Floriano JA, Dos Santos ER, Júnior FNF, Spessoto LCF, Ribeiro RCHM, Bianchin MA, Ribeiro Filho MA, Jericó MC, Oliani AH, Oliani DCMV, Poletti NAA, Faria MAG, André JC. PMID: 42441552 [PubMed - indexed for MEDLINE]
	A multi-mineral intervention is associated with improved intestinal permeability in patients with ulcerative colitis: results from a pilot trial. Front Med (Lausanne) Aslam MN, Turgeon DK, McClintock S, Allen R, Sen A, Varani J. PMID: 42440705 [PubMed]
	Meta-analysis of plant-derived exosome-like nanoparticles for the treatment of ulcerative colitis: efficacy and mechanisms insights. Front Pharmacol Hu X, Wang J, Guo M, Guan C, Wang Y, Wang J, Wu Y, Han S. PMID: 42440456 [PubMed]
	Regenerative Inflammation in IBD: How Type I Interferons and TNF Cross-Talk Converts Epithelial Repair into Therapeutic Response. Cells Hinton EAM, Kemp RA, Schultz M, Gadeock S. PMID: 42439621 [PubMed - indexed for MEDLINE]
	Recent advances in the management of small bowel Crohn's disease. Korean J Intern Med Nam K, Moon HS. PMID: 42438900 [PubMed - indexed for MEDLINE]
	Association between dietary total antioxidant capacity and ulcerative colitis severity: a cross-sectional study. Sci Rep Seyyed Shoura SM, Mahdavi R, Bakhtiari Z, Masnadi Shirazi K, Nikniaz Z. PMID: 42437764 [PubMed - as supplied by publisher]
	Meta-Analysis: Crohn's Disease Exclusion Diet for Induction and Maintenance in Crohn's Disease. Aliment Pharmacol Ther Batra G, Shukla A, Chatterjee A, Chandnani S, Singh A, Yadav DP, Narang H, Josy K, Ghosh TS, Kedia S, Phillip M, Sood A, Ahuja V, Sharma V. PMID: 42437372 [PubMed - as supplied by publisher]
	A Longitudinal Disease Progression Model Characterizing Endoscopic Response and Remission in Crohn's Disease. J Pharmacokinet Pharmacodyn Moein A, Langenhorst J, Kassir N. PMID: 42436336 [PubMed - indexed for MEDLINE]
	Crohn's Disease: From Immune Dysregulation to Intestinal Damage. Inflammation Salvatori S, Frascatani R, De Vico P, Marafini I, Monteleone G. PMID: 42435143 [PubMed - as supplied by publisher]
	Nonconventional dysplasia in ulcerative colitis: a clinicopathological study of 694 patients. Ann Gastroenterol Helal TE, Radwan NA, Halim MI, Elgendy FM. PMID: 42434161 [PubMed]
	Granulocyte and monocyte adsorptive apheresis for ulcerative colitis: mechanisms, clinical evidence, and future perspectives. Ann Gastroenterol Tanaka T, Yoshifuku Y, Teshima H, Konishi H, Nakata K, Kitamura K, Otabe N, Mori T, Cho S, Nonaka M, Fujimoto Y. PMID: 42434156 [PubMed]
	Erratum: Comments on "Association between early crohn's disease (CD) diagnosis and development of clinical complications in adults at King Abdulaziz University Hospital". Ann Med Surg (Lond) PMID: 42433810 [PubMed]
	Shared inflammatory architecture and therapeutic tensions between psoriasis and Crohn's disease. Front Immunol Wang X, Li J, Yu K, Wu X, Luo Q. PMID: 42433375 [PubMed - indexed for MEDLINE]
	Correction to: P0562 Comparative Efficacy and Safety of Upadacitinib Versus Oral Prednisolone for the Induction of Remission in Ulcerative Colitis: A Prospective, Multicenter, Open-label, Randomized Controlled Trial (PREDUPA Trial) ProtocolÂ andÂ P0563 Mirikizumab Demonstrated Sustained and Durable Long-Term Efficacy and Favorable Safety in Week 52 Endoscopic Responders with Crohn's disease: 3-year VIVID-2 Open-Label Extension Interim Results. J Crohns Colitis PMID: 42433038 [PubMed - in process]
	Lymphomatous transformation in mass-forming chronic active EBV-associated enteritis initially misdiagnosed as ulcerative colitis: A case report. Medicine (Baltimore) Yang T, Ding L, Tao M, Chen M, Qin Y. PMID: 42432915 [PubMed - indexed for MEDLINE]
	Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease. JAMA Netw Open Lyu N, Tracy M, Schneeweiss S, Savage TJ. PMID: 42430170 [PubMed - indexed for MEDLINE]
	Redefining Neutrophil Function in Inflammatory Bowel Disease: From Tissue Injury to Immune Resolution. Mol Biol Rep Khademi M, Kazemifard N, Ghavami SB, Farmani M, Shahrokh S. PMID: 42429844 [PubMed - indexed for MEDLINE]
	Sialidase inhibitor modulates gut microbiota and enhances mucosal protection in the treatment of ulcerative colitis. mSystems Zhao Y, Chen L, Li C, Xu Y, Huang J, Chen S, Yu Z, Liu X. PMID: 42429666 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58257

Page 1 of 2913



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy